Century Therapeutics Ownership | Who Owns Century Therapeutics?


OverviewForecastRevenueFinancialsChart

Century Therapeutics Ownership Summary


Century Therapeutics is owned by 42.97% institutional investors, 28.07% insiders, and 28.96% retail investors. Boxer capital is the largest institutional shareholder, holding 7.87% of IPSC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.53% of its assets in Century Therapeutics shares.

IPSC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCentury Therapeutics42.97%28.07%28.96%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Boxer capital4.90M7.87%$12.50M
Bain capital life sciences investors5.41M6.39%$5.46M
Casdin capital5.19M6.13%$5.24M
Vr adviser3.96M4.67%$4.00M
Blackrock2.90M4.65%$7.38M
Blackrock funding, inc. /de3.04M3.59%$3.07M
Fmr2.53M2.99%$2.56M
Vanguard group2.38M2.81%$2.41M
Dafna capital management1.70M2.01%$1.72M
Millennium management1.61M1.90%$1.62M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio1.21M2.31%$1.23M
Boxer capital4.90M0.66%$12.50M
Bain capital life sciences investors5.41M0.64%$5.46M
Dafna capital management1.70M0.44%$1.72M
Superstring capital management lp462.96K0.40%$467.59K
Casdin capital5.19M0.35%$5.24M
Vr adviser3.96M0.27%$4.00M
Index venture life associates vi188.25K0.11%$190.13K
Tang capital management900.00K0.06%$909.00K
Parametrica management27.84K0.04%$28.12K

Top Buyers

HolderShares% AssetsChange
Boxer capital4.90M0.66%3.15M
Casdin capital5.19M0.35%1.98M
Millennium management1.61M0.00%1.47M
Blackrock2.90M0.00%1.40M
Renaissance1.20M0.00%714.68K

Top Sellers

HolderShares% AssetsChange
Vr adviser3.96M0.27%-1.43M
Adage capital partners gp---1.32M
Avidity partners management lp---1.22M
Octagon capital advisors lp---666.83K
Jacobs levy equity management10.58K0.00%-283.36K

New Positions

HolderShares% AssetsChangeValue
Superstring capital management lp462.96K0.40%462.96K$467.59K
Index venture life associates vi188.25K0.11%188.25K$190.13K
Panagora asset management91.75K0.00%91.75K$92.67K
Xtx topco85.99K0.01%85.99K$86.85K
Two sigma investments, lp66.80K0.00%66.80K$67.47K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-12.00
Gamma investing-131.00
Qube research-334.00
Smartleaf asset management-1.61K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024748.82%36,399,688-8.20%421.96%4441.94%10-37.50%
Sep 30, 20246811.48%39,649,236-1.17%461.96%31-20.51%1633.33%
Jun 30, 202460-10.45%40,117,75873.62%644.24%3939.29%11-50.00%
Mar 31, 2024676.35%23,106,28030.72%384.41%28-17.65%2210.00%
Dec 31, 20236314.55%17,675,612-2.13%293.20%3470.00%20-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.31M1.53%-
Fidelity Growth Compy Commingled Pl S1.27M1.47%4.10K
Fidelity Growth Compy Commingled Pl O1.22M1.45%-96.60K
Syncona Ord1.21M1.43%212.28K
iShares Russell 2000 ETF1.05M1.22%-9.07K
Vanguard Institutional Extnd Mkt Idx Tr785.57K0.91%-
Fidelity Growth Company Fund727.92K0.85%-
Fidelity Small Cap Index480.87K0.56%-9.01K
Fidelity Growth Company K6425.61K0.49%-10.80K
iShares Russell 2000 Value ETF402.65K0.47%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 10, 2025Pfeiffenberger Brent President and CEOSell$1.37K
Mar 10, 2025Russotti Gregory See RemarksSell$1.45K
Mar 10, 2025Farid Adrienne Chief Operations OfficerSell$1.45K
Mar 10, 2025Carr Douglas SVP Finance & OperationsSell$762.60
Feb 18, 2025Pfeiffenberger Brent President and CEOSell$27.18K

Insider Transactions Trends


DateBuySell
2025 Q1-7
2024 Q4-2
2024 Q315
2024 Q2-7
2024 Q1-7

IPSC Ownership FAQ


Who Owns Century Therapeutics?

Century Therapeutics shareholders are primarily institutional investors at 42.97%, followed by 28.07% insiders and 28.96% retail investors. The average institutional ownership in Century Therapeutics's industry, Biotech Stocks , is 68.48%, which Century Therapeutics falls below.

Who owns the most shares of Century Therapeutics?

Century Therapeutics’s largest shareholders are Boxer capital (4.9M shares, 7.87%), Bain capital life sciences investors (5.41M shares, 6.39%), and Casdin capital (5.19M shares, 6.13%). Together, they hold 20.38% of Century Therapeutics’s total shares outstanding.

Does Blackrock own Century Therapeutics?

Yes, BlackRock owns 4.65% of Century Therapeutics, totaling 2.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.38M$. In the last quarter, BlackRock increased its holdings by 1.4M shares, a 93.28% change.

Who is Century Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Century Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.31% of its assets in 1.21M Century Therapeutics shares, valued at 1.23M$.

Who is the top mutual fund holder of Century Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Century Therapeutics shares, with 1.53% of its total shares outstanding invested in 1.31M Century Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools